Advertisement

N.S. patients losing access to cannabis in wake of recreational market: advocate

Click to play video: 'Advocates say cannabis access becoming issue for medical patients in N.S.'
Advocates say cannabis access becoming issue for medical patients in N.S.
WATCH: Canada first made access to medical cannabis legal in 2001 but now advocates say there is a lack of accessibility due to the surging recreational market. Alexa MacLean reports – Oct 26, 2018

Medical marijuana advocates in Nova Scotia say the legalization of recreational marijuana has left patients with a lack of access to the medication they need.

“Not only has the recreational market put a substantial strain on access and availability of strains to medical patients, but it’s making those same strains more expensive than they were traditionally available,” said medical marijuana advocate Chris Enns said.

“For example, a particular strain that an individual is buying from a licensed producer in Canada may have been available at $8 a gram. Now patients when they go to purchase that same product from the NSLC, may be paying $10 a gram or more.”

READ MORE: Medical marijuana users left stranded as legalization pinches supply

Access to recreational cannabis has just been legalized in Canada, but access to cannabis for medical purposes was first made legally accessible in 2001.

Story continues below advertisement

Enns owns and operates a medical cannabis dispensary in Halifax and has fought legal battles to continue to serve patients well before recreational cannabis was on the radar.

The latest health and medical news emailed to you every Sunday.

“Before the introduction of the Cannabis Act on Oct. 17, there was certainly a constitutional territory in Canada through which medical cannabis dispensaries were finding a place to operate and fill the gaps for patients who couldn’t access many strains, many derivatives, edibles and concentrates from the current regime,” he said.

According to Health Canada, the Marihuana Medical Access Regulations [MMAR] was implemented in 2001 and allowed people who were authorized by their health practitioners to access dried marijuana through three methods: producing their own plants, appointing someone to produce plants for them, or buying plants through the Health Canada supply.
As of August 2016, the MMAR has been replaced by the Access to Cannabis for Medical Purposes Regulations [ACMPR] and changes vary from new labeling requirements for cannabis oil to analytical testing of the product.
Story continues below advertisement

Now that recreational cannabis has been made legal, Enns says the government has a responsibility to address access barriers that medical patients are struggling with.

“I think there needs to be an intensive dialogue between the provincial governments, the federal government, and licensed producers to make sure that the availability of products is there for patients who need them before it’s made available to the recreational market.”

Sponsored content

AdChoices